OncoImmunology
Volume 1, 2012 - Issue 9
Open access
2,363
Views
293
CrossRef citations to date
0
Altmetric
Original Research
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
Richard Metz New Link Genetics Corporation; Ames, IA USA
, Sonja Rust New Link Genetics Corporation; Ames, IA USA
, James B. DuHadaway Lankenau Institute for Medical Research; Wynnewood, PA USA
, Mario R. Mautino New Link Genetics Corporation; Ames, IA USA
, David H. Munn Immunotherapy Center; Georgia Health Sciences University; Augusta, GA USA
, Nicholas N. Vahanian New Link Genetics Corporation; Ames, IA USA
, Charles J. Link New Link Genetics Corporation; Ames, IA USA
& George C. Prendergast Lankenau Institute for Medical Research; Wynnewood, PA USA; Kimmel Cancer Center; Thomas Jefferson University; Philadelphia, PA USACorrespondence[email protected]
show all
Pages 1460-1468
|
Received 29 Jul 2012, Accepted 03 Aug 2012, Published online: 06 Dec 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.